查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1595313

藥品契約製造與研究服務市場：按服務、最終用戶分類 - 全球預測 2025-2030 年

Pharmaceutical Contract Manufacturing & Research Services Market by Service (Manufacturing, Research), End-User (Big Pharma, Generic Pharmaceutical Companies, Small & Mid-Size Pharma) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，藥品契約製造和研究服務市場價值為2111.4億美元，預計到2024年將達到2255.2億美元，複合年成長率為6.90%，到2030年將達到3368.7億美元，預計將達到1000萬美元。

藥品契約製造和研究服務市場包括向製藥公司提供藥物開發、製造、研究和其他服務的第三方公司。透過外包關鍵職能，市場在幫助製藥公司提高靈活性、降低成本和加快上市時間方面發揮關鍵作用。這些服務的需求源於與內部藥物開發和製造相關的複雜性和高成本。應用包括配方開發、臨床試驗管理和商業製造，最終用戶包括大型製藥公司、生物技術公司和學名藥製造商。

主要市場統計
基準年[2023] 2111.4億美元
預測年份 [2024] 2255.2億美元
預測年份 [2030] 3368.7億美元
複合年成長率（%） 6.90%

關鍵的成長要素包括對生技藥品的需求增加、對具有成本效益的藥物生產的需求不斷成長以及推動公司尋找專業供應商的嚴格監管要求。連續加工和自動化等製造流程的技術進步正在創造巨大的商機。研發投資的增加和學名藥生產的擴張將進一步推動市場。然而，嚴格的監管合規、供應鏈中斷以及契約製造製造商的高初始投資等挑戰可能會阻礙成長。此外，對資料安全和智慧財產權的擔憂也帶來了重大風險。

個人化醫療、先進藥物輸送系統以及在研究服務中引入人工智慧和機器學習等創新領域提供了巨大的商機。企業應專注於發展生物製造平台，加強特色藥物製造能力，以把握未來的成長機會。與科技公司合作利用數位轉型可以進一步使您的服務產品脫穎而出。市場相關人員必須優先考慮建立強力的法律規範和靈活的供應鏈以降低風險。總體而言，這個市場具有不斷變化的需求和競爭格局，具有動態性，為創新和擴張提供了重要的機會，可以透過與最新的技術和監管趨勢保持一致來抓住這些機會。

市場動態：快速發展的藥品契約製造和研究服務市場的關鍵市場洞察

藥品契約製造和研究服務市場正在因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • CDMO增加以及CDMO增加對先進製造技術的投資
    • 增加對藥物開發/發現和先進製造技術的投資
    • 大型製藥企業外包數量增加
  • 市場限制因素
    • 對委外研發機構的監管壓力
  • 市場機會
    • 對專業測試服務的需求不斷成長
    • 標靶治療的細胞和基因療法的需求不斷成長
  • 市場挑戰
    • 貿易政策因國家而異

波特五力策略工具引領藥品契約製造與研究服務市場

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解藥品契約製造和研究服務市場的外部影響

外部宏觀環境因素在塑造藥品契約製造和研究服務市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解藥品契約製造和研究服務市場的競爭狀況

藥品契約製造和研究服務市場的詳細市場佔有率分析提供了對供應商績效的全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣藥品契約製造與研究服務市場供應商的績效評估

FPNV 定位矩陣是評估藥品契約製造和研究服務市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製藥品契約製造和研究服務市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對藥品契約製造和研究服務市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • CDMO數量增加以及CDMO加大對先進製造技術的投資
      • 增加對藥物開發/發現和先進製造技術的投資
      • 大型藥廠外包數量增加
    • 抑制因素
      • 對合約研究機構服務的監管壓力
    • 機會
      • 對專業測試服務的需求不斷成長
      • 對標靶治療的細胞和基因治療的需求不斷增加
    • 任務
      • 各國貿易政策差異
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 藥品契約製造與研究服務市場：依服務分類

  • 製造業
    • 先進的藥物輸送配方包裝
    • 原料藥/原料藥
    • 最終劑量配方
      • 液體配方
      • 半固態製劑
      • 固態製劑
    • 包裹
  • 調查
    • 心臟病學
    • 發炎和免疫學
    • 神經科學
    • 腫瘤學
    • 疫苗

第7章 藥品契約製造與研究服務市場：依最終用戶分類

  • 大型製藥公司
  • 學名藥公司
  • 中小型製藥企業

第8章美洲藥品契約製造與研究服務市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太藥品契約製造與研究服務市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲的醫藥契約製造和研究服務市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AbbVie, Inc.
  • Aenova Holding GmbH
  • Baxter International Inc.
  • Boehringer Ingelheim GmbH
  • Catalent, Inc.
  • Famar Group
  • Grifols SA
  • IQVIA
  • Jubilant Life Sciences Limited
  • Lonza Group
  • Pfizer, Inc.
  • Pharmaceutical Product Development, LLC
  • Recipharm AB
  • Valeant Pharmaceuticals International Inc.
  • Vetter Pharma-Fertigung GmbH & Co. KG
Product Code: MRR-AD36CD898497

The Pharmaceutical Contract Manufacturing & Research Services Market was valued at USD 211.14 billion in 2023, expected to reach USD 225.52 billion in 2024, and is projected to grow at a CAGR of 6.90%, to USD 336.87 billion by 2030.

The Pharmaceutical Contract Manufacturing & Research Services market encompasses third-party companies providing services such as drug development, manufacturing, and research to pharmaceutical firms. This market plays a critical role by allowing pharmaceutical companies to outsource key functions, which can enhance flexibility, reduce costs, and accelerate time to market. The necessity of these services arises from the complexity and high costs associated with in-house drug development and manufacturing. Applications include formulation development, clinical trial management, and commercial production, catering to end-users such as large pharmaceutical firms, biotechnology companies, and generic drug manufacturers.

KEY MARKET STATISTICS
Base Year [2023] USD 211.14 billion
Estimated Year [2024] USD 225.52 billion
Forecast Year [2030] USD 336.87 billion
CAGR (%) 6.90%

Key growth factors include the increasing demand for biologics, the growing need for cost-efficient drug manufacturing, and stringent regulatory requirements pushing companies to seek expert providers. Technological advancements in manufacturing processes, such as continuous processing and automation, offer substantial opportunities. The rise in R&D investment and the expansion of generic drug production further propel the market. However, challenges such as stringent regulatory compliance, supply chain disruptions, and the high initial investment for contract manufacturers may hinder growth. Additionally, data security and intellectual property concerns pose significant risks.

Innovative areas such as personalized medicine, advanced drug delivery systems, and the implementation of AI and machine learning in research services present significant opportunities. Companies should focus on developing platforms for biomanufacturing and enhancing their capabilities in specialized drug production to capture future growth. Collaboration with tech firms to leverage digital transformation can further distinguish service offerings. Market players must prioritize building robust regulatory frameworks and agile supply chains to mitigate risks. Overall, this market bears a dynamic nature with evolving demands and a competitive landscape, offering vast opportunities for innovation and expansion that can be seized by aligning with the latest technological and regulatory trends.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmaceutical Contract Manufacturing & Research Services Market

The Pharmaceutical Contract Manufacturing & Research Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing number of CDMOs and rising investments in advanced manufacturing technologies by CDMOs
    • Rising investments in drug development & discovery and advanced manufacturing technologies
    • Growing outsourcing volume by big pharmaceutical companies
  • Market Restraints
    • Regulatory pressure on contract research organization services
  • Market Opportunities
    • Growing demand for specialized testing services
    • Growing demand for cell and gene therapies for targeted treatment
  • Market Challenges
    • Variable trade policies between countries

Porter's Five Forces: A Strategic Tool for Navigating the Pharmaceutical Contract Manufacturing & Research Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmaceutical Contract Manufacturing & Research Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmaceutical Contract Manufacturing & Research Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmaceutical Contract Manufacturing & Research Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmaceutical Contract Manufacturing & Research Services Market

A detailed market share analysis in the Pharmaceutical Contract Manufacturing & Research Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmaceutical Contract Manufacturing & Research Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmaceutical Contract Manufacturing & Research Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmaceutical Contract Manufacturing & Research Services Market

A strategic analysis of the Pharmaceutical Contract Manufacturing & Research Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Contract Manufacturing & Research Services Market, highlighting leading vendors and their innovative profiles. These include AbbVie, Inc., Aenova Holding GmbH, Baxter International Inc., Boehringer Ingelheim GmbH, Catalent, Inc., Famar Group, Grifols S.A, IQVIA, Jubilant Life Sciences Limited, Lonza Group, Pfizer, Inc., Pharmaceutical Product Development, LLC, Recipharm AB, Valeant Pharmaceuticals International Inc., and Vetter Pharma-Fertigung GmbH & Co. KG.

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Contract Manufacturing & Research Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Service, market is studied across Manufacturing and Research. The Manufacturing is further studied across Advanced Drug Delivery Formulations Packaging, API/Bulk Drugs, Finished Dose Formulations, and Packaging. The Finished Dose Formulations is further studied across Liquid Formulations, Semi-Solid Formulations, and Solid Formulations. The Research is further studied across Cardiology, Inflammation & Immunology, Neuroscience, Oncology, and Vaccines.
  • Based on End-User, market is studied across Big Pharma, Generic Pharmaceutical Companies, and Small & Mid-Size Pharma.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing number of CDMOs and rising investments in advanced manufacturing technologies by CDMOs
      • 5.1.1.2. Rising investments in drug development & discovery and advanced manufacturing technologies
      • 5.1.1.3. Growing outsourcing volume by big pharmaceutical companies
    • 5.1.2. Restraints
      • 5.1.2.1. Regulatory pressure on contract research organization services
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing demand for specialized testing services
      • 5.1.3.2. Growing demand for cell and gene therapies for targeted treatment
    • 5.1.4. Challenges
      • 5.1.4.1. Variable trade policies between countries
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pharmaceutical Contract Manufacturing & Research Services Market, by Service

  • 6.1. Introduction
  • 6.2. Manufacturing
    • 6.2.1. Advanced Drug Delivery Formulations Packaging
    • 6.2.2. API/Bulk Drugs
    • 6.2.3. Finished Dose Formulations
      • 6.2.3.1. Liquid Formulations
      • 6.2.3.2. Semi-Solid Formulations
      • 6.2.3.3. Solid Formulations
    • 6.2.4. Packaging
  • 6.3. Research
    • 6.3.1. Cardiology
    • 6.3.2. Inflammation & Immunology
    • 6.3.3. Neuroscience
    • 6.3.4. Oncology
    • 6.3.5. Vaccines

7. Pharmaceutical Contract Manufacturing & Research Services Market, by End-User

  • 7.1. Introduction
  • 7.2. Big Pharma
  • 7.3. Generic Pharmaceutical Companies
  • 7.4. Small & Mid-Size Pharma

8. Americas Pharmaceutical Contract Manufacturing & Research Services Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Pharmaceutical Contract Manufacturing & Research Services Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Pharmaceutical Contract Manufacturing & Research Services Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie, Inc.
  • 2. Aenova Holding GmbH
  • 3. Baxter International Inc.
  • 4. Boehringer Ingelheim GmbH
  • 5. Catalent, Inc.
  • 6. Famar Group
  • 7. Grifols S.A
  • 8. IQVIA
  • 9. Jubilant Life Sciences Limited
  • 10. Lonza Group
  • 11. Pfizer, Inc.
  • 12. Pharmaceutical Product Development, LLC
  • 13. Recipharm AB
  • 14. Valeant Pharmaceuticals International Inc.
  • 15. Vetter Pharma-Fertigung GmbH & Co. KG

LIST OF FIGURES

  • FIGURE 1. PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET RESEARCH PROCESS
  • FIGURE 2. PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY ADVANCED DRUG DELIVERY FORMULATIONS PACKAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY API/BULK DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SEMI-SOLID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SOLID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY PACKAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY INFLAMMATION & IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY NEUROSCIENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY BIG PHARMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY GENERIC PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SMALL & MID-SIZE PHARMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 238. PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 239. PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET, FPNV POSITIONING MATRIX, 2023